This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  86R5898 MEW-D
 
  By: Price H.B. No. 1291
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to prohibited practices by a life insurance company
  relating to an individual's prescription for or obtainment of an
  opioid antagonist.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Chapter 1101, Insurance Code, is amended by
  adding Subchapter E to read as follows:
  SUBCHAPTER E. PROHIBITED PRACTICES RELATING TO PRESCRIPTION FOR OR
  OBTAINMENT OF OPIOID ANTAGONIST
         Sec. 1101.201.  DEFINITION. In this subchapter, "opioid
  antagonist" means any drug that binds to opioid receptors and
  blocks or otherwise inhibits the effects of opioids acting on those
  receptors. 
         Sec. 1101.202.  APPLICABILITY OF SUBCHAPTER. This
  subchapter applies to a life insurance policy:
               (1)  issued or delivered in this state; or
               (2)  issued by a life insurance company organized in
  this state.
         Sec. 1101.203.  PROHIBITION. (a)  Except as provided by
  Subsection (b), a life insurance company may not, because an
  individual has been prescribed or has obtained through a standing
  order an opioid antagonist:
               (1)  deny coverage to the individual;
               (2)  refuse to renew the individual's coverage;
               (3)  cancel the individual's coverage;
               (4)  limit the amount, extent, or kind of coverage
  available to the individual; or
               (5)  charge the individual or a group to which the
  individual belongs a rate that is different from the rate charged to
  other individuals or groups, respectively, for the same coverage.
         (b)  Subsection (a) does not apply to an individual who has a
  demonstrated history of drug abuse.
         SECTION 2.  This Act takes effect September 1, 2019.